Author Photo
Written by:

Benicar® Safety Concerns

| Read Time: < 1 minute

There is growing concern over serious side effects related to the following prescription medications: Benicar®, Benicar HCT®, Tribenzor®, and Azor®.

These medications are prescribed for the treatment of high blood pressure and contain the ingredient olmesartan medoxomil.

Benciar®, Benicar HCT®, Tribenzor®, and Azor® are all brand name drugs which are manufactured by Daiichi Sankyo, Inc., a Japanese corporation. Recent studies have shown that these prescription medications can cause alarming injuries among users, including the following: dehydration, severe weight loss, chronic diarrhea, vomiting, and spruelike enteropathy.

A 2012 study by the Mayo Clinic followed 22 patients who were taking drugs containing olmesartan medoxomil and suffering from chronic diarrhea and weight loss, with most requiring hospitalization. All study participants showed significant improvement of their symptoms after they discontinued the use of drugs containing olmesartan medoxomil.

The study concluded that olmesartan medoxomil was directly linked to the patients’ alarming injuries.

In July of 2013, the United States Food and Drug Administration issued a Safety Announcement which warned of the link between the use of olmesartan medoxomil and serious gastrointestinal side effects, such as chronic diarrhea and weight loss.

Drug injury lawyers at Cory Watson Attorneys are currently investigating claims by individuals who suffered severe gastrointestinal side effects after taking Benciar®, Benicar HCT®, Tribenzor®, and Azor®.

Contact us today for a free case evaluation.

Never stop taking any medication without consulting your doctor.
Benicar® is a registered trademark licensed by Daiichi Sankyo, Inc. and is used herein only to identify the product in question. This law firm is not associated with, sponsored by, or affiliated with Benicar®, Daiichi Sankyo, Inc.
  • Subscribe to Our Blog